Founded in 2004, Sundia MediTech Company, Ltd. is a leading pre-clinical contract research organization (CRO) providing a comprehensive and integrated portfolio of high-quality drug discovery and development services. Sundia's experienced R&D and international management team possess extensive experience across the fields of chemistry (custom synthesis, library design and synthesis), medicinal chemistry, biology (in vitro and in vivo), DMPK, pre-clinical studies, as well as pharmaceutical development (process research and development, API manufacturing, pre-formulation and formulation, analytical as well as QA/QC, CMC and IND filing) services.
Sundia's primary research facilities, which include standard and kilo-labs, an animal facility, a pilot plant and other supporting facilities, are located in Shanghai (Zhangjiang Hi-Tech Park), Shijiazhuang and Taicang. For more information, please visit us at www.sundia.com or email us at info@sundia.com.
Sundia's primary research facilities, which include standard and kilo-labs, an animal facility, a pilot plant and other supporting facilities, are located in Shanghai (Zhangjiang Hi-Tech Park), Shijiazhuang and Taicang. For more information, please visit us at www.sundia.com or email us at info@sundia.com.
Location: China, Shanghai
Employees: 501-1000
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | Darwin Man... | darwin-ven... |
Mentions in press and media 1
| Date | Title | Description |
| 16.01.2008 | Life sciences briefing: Wednesday, Jan. 16, 2008 | TODAY’S HEADLINES: Drug-screening tool maker IonGate Bio raises €4.6M (release) Protein-drug maker Molecular Partners gets $5M up front in Centocor deal (PDF release) ProtaGen takes in €1M for protein biochips (PDF release) China’s Sundia M... |